News

iBio, Inc., a biotech innovator and biologics contract manufacturing organization, announced that it has entered into a Master Services Agreement (“MSA”) with Boston-based Safi Biosolutions, Inc. (“Safi”) to evaluate iBio’s FastPharming® System for the expression of key proteins to...

Kodiak Sciences Inc., a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases, announced that the first patients have been treated in the randomized, double-masked GLEAM, GLIMMER and BEACON studies, three pivotal...

Blue Dart, India’s leading express logistics service provider and part of the Deutsche Post DHL Group (DPDHL) with its commitment to help improve the supply chain and ensure timely medical provisions is ramping up its infrastructure with its pre-existing...

Samsung Bioepis Co., Ltd. and Biogen Inc. announced that the European Medicines Agency (EMA) has accepted for review the Marketing Authorisation Application for SB11, a proposed biosimilar referencing Lucentis® (ranibizumab). Ranibizumab is an anti-VEGF (vascular endothelial growth factor) for...

The maker of the first antiviral drug to get authorization from regulators for Covid-19 anticipates meeting real-time demand for it around the world this month and is already meeting demand in the U.S. Foster City, California-based Gilead Sciences said Thursday...

DuPont announced it will participate in the virtual CPhI: Festival of Pharma, highlighting its commitment to meet customers’ needs for essential innovations to address the challenges of the COVID-19 global pandemic. DuPont’s technical leaders will draw upon their decades of...

ValGenesis Inc., a market leader in Enterprise Validation Lifecycle Management Solutions (VLMS), announced that it has digitized the validation process at Dr. Reddy's Laboratories across multiple sites, driven by ValGenesis VLMS – the industry's most trusted electronic validation lifecycle...